India · Delayed Price · Currency is INR Vista Pharmaceuticals Statistics
Total Valuation
BOM:524711 has a market cap or net worth of INR 411.78 million. The enterprise value is 495.48 million.
| Market Cap | 411.78M |
| Enterprise Value | 495.48M |
Important Dates
The last earnings date was Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:524711 has 61.55 million shares outstanding. The number of shares has increased by 5.50% in one year.
| Current Share Class | 61.55M |
| Shares Outstanding | 61.55M |
| Shares Change (YoY) | +5.50% |
| Shares Change (QoQ) | -8.21% |
| Owned by Insiders (%) | 65.58% |
| Owned by Institutions (%) | n/a |
| Float | 13.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.77 |
| PB Ratio | 0.92 |
| P/TBV Ratio | 1.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.44 |
| EV / Sales | 5.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.70 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -17.13% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 3.20% |
| Revenue Per Employee | 2.88M |
| Profits Per Employee | -2.56M |
| Employee Count | 30 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -17.51M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.96% in the last 52 weeks. The beta is -0.32, so BOM:524711's price volatility has been lower than the market average.
| Beta (5Y) | -0.32 |
| 52-Week Price Change | -38.96% |
| 50-Day Moving Average | 7.71 |
| 200-Day Moving Average | 9.46 |
| Relative Strength Index (RSI) | 38.58 |
| Average Volume (20 Days) | 18,822 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:524711 had revenue of INR 86.30 million and -76.94 million in losses. Loss per share was -1.32.
| Revenue | 86.30M |
| Gross Profit | 5.25M |
| Operating Income | -90.78M |
| Pretax Income | -94.45M |
| Net Income | -76.94M |
| EBITDA | -83.26M |
| EBIT | -90.78M |
| Loss Per Share | -1.32 |
Balance Sheet
The company has 1.33 million in cash and 85.02 million in debt, with a net cash position of -83.69 million or -1.36 per share.
| Cash & Cash Equivalents | 1.33M |
| Total Debt | 85.02M |
| Net Cash | -83.69M |
| Net Cash Per Share | -1.36 |
| Equity (Book Value) | 446.39M |
| Book Value Per Share | 7.24 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 6.08%, with operating and profit margins of -105.19% and -89.16%.
| Gross Margin | 6.08% |
| Operating Margin | -105.19% |
| Pretax Margin | -109.44% |
| Profit Margin | -89.16% |
| EBITDA Margin | -96.48% |
| EBIT Margin | -105.19% |
| FCF Margin | n/a |
Dividends & Yields
BOM:524711 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.50% |
| Shareholder Yield | -5.50% |
| Earnings Yield | -18.68% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 25, 2015. It was a forward split with a ratio of 1.6666666667.
| Last Split Date | Jun 25, 2015 |
| Split Type | Forward |
| Split Ratio | 1.6666666667 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |